Related Experiment Videos

Cycloplegic refraction in esotropic children. Cyclopentolate versus atropine

Ophthalmology
|October 1, 1981
PubMed

Insights

Atropine eye drops are essential for accurately measuring hyperopia in young children with esotropia. Some children require atropine to reveal significant hyperopia missed by cyclopentolate, impacting treatment decisions.

Area of Science:

  • Ophthalmology
  • Pediatric Optometry
  • Clinical Refraction

Background:

  • Esotropia in young children often involves hyperopia.
  • Accurate refractive error assessment is crucial for managing esotropia.
  • Cyclopentolate and atropine are commonly used cycloplegic agents.

Purpose of the Study:

  • To compare the efficacy of atropine versus cyclopentolate in uncovering hyperopia in esotropic children.
  • To determine if atropine cycloplegia is necessary for comprehensive hyperopia assessment in this population.

Main Methods:

  • Retinoscopy was performed on esotropic children under 5.5 years old.
  • Two cycloplegic agents were used: cyclopentolate 1% and atropine 1.0%.
  • Hyperopic refractive errors were compared between the two agents.

Main Results:

  • Atropine 1.0% revealed an average of +0.34 diopters more hyperopia than cyclopentolate 1.0%.
  • 22% of children had 1.0 diopter or more of hyperopia uncovered by atropine.
  • This significant subgroup often had initial cyclopentolate retinoscopy readings of +2.00 diopters or more.

Conclusions:

  • Atropine cycloplegia is essential for uncovering the maximum hyperopic refractive error in young esotropic children.
  • Routine atropine refraction is recommended for this patient group to ensure accurate diagnosis and treatment.
  • The need for atropine may be more pronounced in children over 2 years old, though not statistically significant.

Related Concept Videos